Reverse BioEngineering, Inc.
Alameda, CA, US· latest recorded location
Reverse BioEngineering, Inc. is named on 2 US grants and 4 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 2
- Published applications
- 4
- Inventors
- 3
- Granted in 2026 so far
- 0
- Most recent grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2024 | 0 | 1 |
| 2025 | 2 | 3 |
By publication year.
Technology areas
Share of 6 documents
- A61KMedicines and medical preparations6
- A61PTherapeutic uses of medicines5
- C12NMicroorganisms or enzymes5
- C07KPeptides4
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1
- C12YEnzymes1
- G01NInvestigating or analysing materials by determining their chemical or physical properties1
Recent patents
- Compositions and methods for induced tissue regeneration in mammalian species9 Dec 2025US 12,492,400 B2
- Compositions and methods for induced tissue regeneration in mammalian species23 Sep 2025US 12,421,513 B2
- Compositions and methods for induced tissue regeneration in mammalian species27 Nov 2025US 2025/0361510 A1
- Use of protocadherins in methods of diagnosing and treating cancer12 Jun 2025US 2025/0188183 A1
- Improved methods for inducing the maturation of mammalian cells20 Feb 2025US 2025/0059505 A1
- Methods for the temporal regulation of reprogramming factors in mammalian cells5 Dec 2024US 2024/0398987 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.